At a glance

ClinicalIndex Comparison Record

N/ACompleted· 16 enrolled

Drug / intervention

Sativex +1 moredrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01748799

NCT01748799N/ACompleted

Compare CT.gov

Effects of Fixed or Self-Titrated Dosages of Sativex on Cannabis Users

Centre for Addiction and Mental Health·interventional·Posted Dec 13, 2012·Updated Feb 1, 2016

In Brief

A clinical study evaluating Sativex and Placebo for Cannabis Dependence. Completed, enrolled 16 participants across 1 site.

Detailed Summary

The purpose of this study is to to demonstrate the feasibility and tolerability of the use of Sativex in cannabis dependent individuals and to assess the effects of fixed or self titrated dosages of SATIVEX® (Δ9-tetrahydrocannabinol /cannabidiol combination in a buccal spray) on withdrawal symptoms, craving scores and cannabis consumption during the study period.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsCannabis Dependence

CountriesCanada

CollaboratorsCanadian Institutes of Health Research (CIHR)

Timeline

N/ACompletedFinished

20132014201520162017201820192020202120222023202420252026

First PostedDec 2012

Enrollment StartFeb 2013

Primary CompletionSep 2014

TodayJul 2026

First PostedDec 13, 2012

Enrollment StartFeb 1, 2013

Primary CompletionSep 1, 2014

TodayJul 2, 2026

Enrollment to primary: 1.6 yearsPosted 13.6 years ago

Interventions

Sativexdrug

All participants received the same interventions (Fixed or Self-Titrated Sativex), just in different sequences.

Placebodrug

All participants received the same interventions (Fixed or Self-Titrated Placebo), just in different sequences.